Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paolo Masia"'
Autor:
Maria Scherma, Maria Francesca Palmas, Augusta Pisanu, Paolo Masia, Simona Dedoni, Chiara Camoglio, Walter Fratta, Anna R. Carta, Paola Fadda
Publikováno v:
Nutrients, Vol 15, Iss 17, p 3830 (2023)
Anorexia nervosa (AN) is a complex eating disorder characterized by reduced caloric intake to achieve body-weight loss. Furthermore, over-exercise is commonly reported. In recent years, animal models of AN have provided evidence for neuroplasticity c
Externí odkaz:
https://doaj.org/article/c6384681a1d44592b5440b0ebd629fbf
Publikováno v:
Medicines, Vol 5, Iss 4, p 107 (2018)
Following the discovery of the endocannabinoid system and its potential as a therapeutic target for various pathological conditions, growing interest led researchers to investigate the role of cannabis and its derivatives for medical purposes. The co
Externí odkaz:
https://doaj.org/article/0a1216d7785d42e5af545fa9ea32d02c
Autor:
Shao-shan Carol Huang, Matteo Deidda, Paolo Masia, Maria Scherma, Ya B. Wei, Walter Fratta, Johanna S. Qvist, Paola Fadda, Arun Asok, Philippe A. Melas, Rajesh Kumar Soni, Eric R. Kandel, Denise B. Kandel
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance The endocannabinoid system has a modulatory role in brain reward and cognitive processes. It has been hypothesized that repeated interference with endocannabinoid signaling (e.g., through abuse of cannabis or synthetic cannabinoids) can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538ba562ee9dfcf5e36d93837fd55b48
https://pubmed.ncbi.nlm.nih.gov/32312805
https://pubmed.ncbi.nlm.nih.gov/32312805
Publikováno v:
Medicines
Medicines, Vol 5, Iss 4, p 107 (2018)
Medicines, Vol 5, Iss 4, p 107 (2018)
Following the discovery of the endocannabinoid system and its potential as a therapeutic target for various pathological conditions, growing interest led researchers to investigate the role of cannabis and its derivatives for medical purposes. The co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b58a4a81576fc57496ebab419b1af6c
https://pubmed.ncbi.nlm.nih.gov/30279403
https://pubmed.ncbi.nlm.nih.gov/30279403
Publikováno v:
Acta pharmacologica Sinica. 40(3)
Anandamide is a lipid mediator that acts as an endogenous ligand of CB1 receptors. These receptors are also the primary molecular target responsible for the pharmacological effects of Δ9-tetrahydrocannabinol, the psychoactive ingredient in Cannabis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c58f6850cbc995423040071565ab73fe
https://pubmed.ncbi.nlm.nih.gov/30050084
https://pubmed.ncbi.nlm.nih.gov/30050084